Clinical Trial Update: Chlorpheniramine Maleate Nasal Spray for Chronic Rhinitis [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 clinical trial of chlorpheniramine maleate nasal spray for allergic rhinitis and nasal congestion was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis
• Nasal Congestion

Drugs mentioned

• Chlorpheniramine maleate nasal spray (chlorpheniramine maleate)

Snippet

Sponsor: Larkin Community Hospital | Conditions: Allergic Rhinitis, Nasal Congestion | Phase 2, Phase 3 | Status: WITHDRAWN